A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.
This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.
Read Also
- The Fiesole press release: “Anti-Covid restrictions, we stay out” Aug 22, 2021
- Covid, Iss: “Most new infections in unvaccinated” Jul 11, 2021
- Alert! When you look at these facts, Corona in the world makes goosebumps Apr 19, 2021
- Coronavirus Russia records record of deaths from covid in 24 hours Aug 26, 2021
- Make an Informed Decision: 8 Elements to Look for in Your Health Insurance Policy Jul 9, 2021
- Ministry of Health confirms over 1,635 deaths and 54.5 thousand covid cases Jul 3, 2021
- Covid, Pregliasco: “Those who say no to vaccine show no alternatives” Sep 8, 2021